1. Home
  2. BTOC vs APVO Comparison

BTOC vs APVO Comparison

Compare BTOC & APVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

BTOC

Armlogi Holding Corp.

N/A

Current Price

$1.91

Market Cap

4.9M

Sector

N/A

ML Signal

N/A

Logo Aptevo Therapeutics Inc.

APVO

Aptevo Therapeutics Inc.

N/A

Current Price

$0.41

Market Cap

4.3M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
BTOC
APVO
Founded
2020
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.9M
4.3M
IPO Year
2023
2023

Fundamental Metrics

Financial Performance
Metric
BTOC
APVO
Price
$1.91
$0.41
Analyst Decision
Analyst Count
0
0
Target Price
N/A
★ $25.50
AVG Volume (30 Days)
43.6K
★ 83.8K
Earning Date
11-16-2026
11-16-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 0.13
EPS
★ N/A
N/A
Revenue
★ $185,835,053.00
$3,114,000.00
Revenue This Year
$55.17
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$0.15
$0.43
52 Week High
$11.49
$10.70

Technical Indicators

Market Signals
Indicator
BTOC
APVO
Relative Strength Index (RSI) 44.13 8.72
Support Level $0.15 N/A
Resistance Level $5.29 $1.98
Average True Range (ATR) 0.33 0.11
MACD 0.05 -0.06
Stochastic Oscillator 14.09 0.29

Price Performance

Historical Comparison
BTOC
APVO

About BTOC Armlogi Holding Corp.

Armlogi Holding Corp is a fast-growing U.S.-based warehousing and logistics service provider that offers a comprehensive package of supply-chain solutions relating to warehouse management and order fulfillment. The company provides one-stop warehousing and logistics services to cross-border e-commerce merchants outside the U.S. who seek to sell in the U.S. market. The warehouses are equipped with automated sorting systems, heavy-duty forklifts, and pallets and trays that are suitable for processing bulky items. The services of the company include customs brokerage services, transportation of merchandise to U.S. warehouses, and warehouse management and order fulfillment services.

About APVO Aptevo Therapeutics Inc.

Aptevo Therapeutics Inc is a clinical-stage research and development biotechnology company focused on developing novel immunotherapeutic candidates for the treatment of different forms of cancer. Its clinical candidates are; ALG.APV-527, which targets co-stimulatory receptors and tumor antigens, and CD3xCD123, which is being developed as a potential treatment of frontline acute myelogenous leukemia. The company's preclinical candidates, APVO711, CD3xCD123, APVO0442, and APVO603, are being developed using the ADAPTIR modular protein technology platform. The company's versatile and robust ADAPTIR and ADAPTIR-FLEX platforms are designed to generate monospecific, bispecific, and multi-specific antibody candidates that are capable of enhancing the human immune system against cancer cells.

Share on Social Networks: